Inventor profile of:

Kyle E. Parcella

City:

Branford, Connecticut

Country:

United States

Published Applications:

19

Last publication date:

2026-05-07

Top Assignees for applications by Kyle E. Parcella

The entities that hold a legal rights for patent applications filed by inventor Parcella Kyle E.:

Recent patent applications by Parcella Kyle E.

Kyle E. Parcella from Branford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-07
US20260124209A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#2 | 2025-08-07
US20250249005A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#3 | 2024-11-14
US20240374598A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#4 | 2023-05-18
US20230149408A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#5 | 2023-04-06
US20230109662A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#6 | 2023-01-19
US20230013823A1
Chemistry; metallurgy

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#7 | 2022-12-08
US20220389007A1
Chemistry; metallurgy

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#8 | 2022-11-24
US20220370451A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#9 | 2022-03-24
US20220089598A1
Chemistry; metallurgy

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#10 | 2021-12-30
US20210403465A1
Chemistry; metallurgy

QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#11 | 2021-12-23
US20210395262A1
Chemistry; metallurgy

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#12 | 2021-12-23
US20210395248A1
Chemistry; metallurgy

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#13 | 2021-12-23
US20210393633A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#14 | 2021-12-09
US20210379071A1
Human necessities

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#15 | 2021-01-28
US20210024503A1
Chemistry; metallurgy

4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication

#16 | 2020-11-19
US20200360384A1
Human necessities

Inhibitors of human immunodeficiency virus replication

#17 | 2020-02-20
US20200055839A1
Chemistry; metallurgy

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#18 | 2020-01-16
US20200016136A1
Human necessities

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#19 | 2019-03-28
US20190092754A1
Chemistry; metallurgy

5-(N-BENZYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

InventorID:

2464629 ⎘